These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38491277)

  • 1. Biologic patent challenges under the America Invents Act.
    Van de Wiele VL; Kesselheim AS; Tu SS
    Nat Biotechnol; 2024 Mar; 42(3):374-377. PubMed ID: 38491277
    [No Abstract]   [Full Text] [Related]  

  • 2. Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act.
    Laporte C; Deneke CC; Banks D
    Pharm Pat Anal; 2015; 4(4):247-51. PubMed ID: 26174564
    [No Abstract]   [Full Text] [Related]  

  • 3. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected?
    Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS
    Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-to-invent versus first-to-file: impact of the AIA.
    Rachinsky T; Sullivan C; Ghosh S; Resnick DS; Burton C; Armstrong M; Hanish JP; Sklan A
    Pharm Pat Anal; 2014 Jul; 3(4):353-9. PubMed ID: 25291309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The America Invents Act: summarizing the statute.
    Calkins J
    Pharm Pat Anal; 2012 Mar; 1(1):13-6. PubMed ID: 24236707
    [No Abstract]   [Full Text] [Related]  

  • 7. Patent owner options for correcting errors in US patents after grant.
    Armstrong M
    Pharm Pat Anal; 2014 Sep; 3(5):499-508. PubMed ID: 25374319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-Therasense inequitable conduct: a pharmaceutical perspective.
    Carson PA; Forchheimer D; Draper DN
    Pharm Pat Anal; 2013 Jul; 2(4):467-79. PubMed ID: 24237124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell patents after the america invents act.
    Sherkow JS; Scott CT
    Cell Stem Cell; 2015 May; 16(5):461-4. PubMed ID: 25957901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic products in the drug industry.
    PIERSMA HD
    Biomed Purv; 1963; 3():59-70. PubMed ID: 13943460
    [No Abstract]   [Full Text] [Related]  

  • 11. Ancillary Product Patents to Extend Biologic Patent Life.
    Goode R; Feldman WB; Tu SS
    JAMA; 2023 Dec; 330(21):2117-2119. PubMed ID: 37955940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic notebooks in the post-america invents act world.
    Palovich TU
    ACS Med Chem Lett; 2014 Dec; 5(12):1266-7. PubMed ID: 25516781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-to-patent does not predict first- or best-in-class: analysis of approved small molecule vs. biologic drugs.
    Roland GE; Xu JJ; Wagner JA
    Clin Pharmacol Ther; 2015 Jan; 97(1):19-21. PubMed ID: 25670379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter Partes Review: Patent Killer No More?
    Chen FC; Lee PS
    Trends Biotechnol; 2019 Jul; 37(7):680-683. PubMed ID: 30890272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of America Invents Act on Biotech Intellectual Property.
    Murphy A; Stramiello M; Stroud J; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a020784. PubMed ID: 25918182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The america invents act-overview and implications: patent highlight.
    Hollinger S
    ACS Med Chem Lett; 2012 Mar; 3(3):174-6. PubMed ID: 24900452
    [No Abstract]   [Full Text] [Related]  

  • 17. REGULATION governing the establishment and operation of pharmaceutical drug, and/or biological manufacturing laboratories, and the distribution and sale of pharmaceutical and biologic products.
    J Philipp Med Assoc; 1953 Feb; 29(2):74-82. PubMed ID: 13035712
    [No Abstract]   [Full Text] [Related]  

  • 18. Fresh from the biologic pipeline--2010.
    Kling J
    Nat Biotechnol; 2011 Mar; 29(3):197-200. PubMed ID: 21390016
    [No Abstract]   [Full Text] [Related]  

  • 19. The America Invents Act implementation.
    Hollinger S
    Expert Opin Ther Pat; 2013 May; 23(5):545-8. PubMed ID: 23560953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective.
    Sreedhara A; Zamiri C; Goswami S; Weiser S; Cram M; Christian TR; Jagannathan B
    J Pharm Sci; 2020 Jan; 109(1):22-29. PubMed ID: 31697946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.